Random42

Last updated
Random42
Company type Private
IndustryScientific visualisation
Founded1992;33 years ago (1992)
FounderHugo Paice
Headquarters
Marylebone, London
,
United Kingdom
Area served
Worldwide
Key people
  • Ben Ramsbottom (CEO)
  • Andy Kay (CFO)
  • Eleanor Spreckley (Medical Director)
ProductsScientific Visual Storytelling
Website www.random42.com

Random42 is a British medical animation studio based in central London. [1] It was founded in 1992 by Hugo Paice, focusing primarily on creating animations for the pharmaceutical industry. This has now diversified to a variety of other digital services, including virtual reality, interactive apps, interactive touchscreens, augmented reality as well as booth installations. [2]

Contents

In 2018, Random42 was listed as one of the fastest-growing companies in the UK pharmaceutical industry, with its inclusion on Alantra's Pharma Fast 50 list. [3]

Clients

Random42 produces scientific and medical visual content for clients in the pharmaceutical and biotechnology industries. [4] In addition to work in the pharmaceutical sector, the company has created content for areas such as consumer health, medical devices, diagnostics, and animal health. [5] [6] Random42 has also collaborated with the film industry on science-related documentaries, some of which have been screened in IMAX theaters and on streaming platforms like Netflix. [4]

References

  1. "RANDOM42 LIMITED overview". GOV.UK. Retrieved 2025-05-26.
  2. "Company Overview of Random42 Limited". Bloomberg. Retrieved 18 February 2018.
  3. "Alantra Pharma Fast 50 – 2021" (PDF). alantra.com. 1 March 2021. Retrieved 2025-05-26.
  4. 1 2 "List of Random42 clients". random42.com. Retrieved 2025-05-26.
  5. Kanvaria, Dr Vinod Kumar (2023). Augmented Reality & Virtual Reality. Archers & Elevators Publishing House. p. 395. ISBN   978-93-94958-48-7.
  6. Asmi, Fahad (2023-03-24). Role of immersive media in public understanding of socio scientific issues (SSIs) . 3D Medical Animation. p. 23. ISBN   978-2-8325-1886-1.